Source: International Congress 2014 – Airway biomarkers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Barta, O. Drozdovszky, B. Antus (Budapest, Hungary). Monitoring exhaled carbon monoxide in COPD exacerbations. Eur Respir J 2014; 44: Suppl. 58, 999

Member's Comments

No comment yet.

Related content which might interest you: Exhaled breath condensate hydrogen peroxide in obstructive airways disease Source: International Congress 2014 – Airway biomarkers Year: 2014 Hydrogen sulfide (H2S) in sputum and serum as a novel biomarker of COPD Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Assessment of malondialdehyde in the airways during treatment of COPD exacerbations Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Hydrogen sulphide as a biomarker in COPD and asthma Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Monitoring catalase activity in COPD exacerbations Source: International Congress 2016 – Airway biomarkers Year: 2016 Double-tracer gas washout in stable asthma and COPD Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Prediction of the duration of hospitilization in acute COPD exacerbations: The AECOPD-F score Source: International Congress 2014 – Monitoring COPD with different biomarkers Year: 2014 Small airways obstruction and exhaled particles in asthma Source: International Congress 2014 – Biomarkers of asthma control Year: 2014 Metabolomic analysis of exhaled breath condensate in patients with asthma and COPD Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Exhaled particles from small airways in COPD patients – A pilot study Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Induced sputum and bronchial hyperresponsiveness in COPD patients Source: International Congress 2014 – Airway biomarkers Year: 2014 The amount of endogenous particles in exhaled air is correlated to peripheral airway obstruction Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Exacerbations and healthcare resource utilization among COPD patients in Sweden Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Neutrophil/lymphocyte (NLR) ratio in infectious acute exacerbations of COPD (AECOPD) Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Blood eosinophils and outcomes in COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Laboratory and clinical parameters in predicting risk of future exacerbations in both non-smoking and smoking COPD patients Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Etiological structure from sputum of patients with exacerbation of COPD Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014 Volatile organic compounds in exhaled breath of patients with COPD ± lung cancer and their correlation with FEV1-values Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Effect of tiotropium on exhaled breath temperature in patients with COPD Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013 Role of comorbidities on mortality in patients hospitalized for COPD exacerbations Source: International Congress 2014 – The assessment of comorbidities Year: 2014